Maintaining Full-Year 2026 Guidance, But Seeing Additional Earnings Pressure in 1Q26PERRYSBURG, Ohio, Feb. 25, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE John Haudrich, Chief Financial Officer of O-I Glass, Inc. (“O-I,” NYSE: OI), will present at the BofA Securities 2026 Global Agriculture and Materials Conference on Wednesday, February 25, 2026, at 10:30 a.m. ET. During the presentation, O-I will outline its strategy to enhance shareholder value through improved competitiveness, disciplined cost trans ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hub Group Inc. (NASDAQ:HUBG) for potential violations of the federal securities laws. If you invested in Hub Group, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/hub-group-class-action-lawsuit. Why is Hub Group Being Investigated for Violations of the Federal Securities Laws? Hub Group is a supply chain solutions provider that off ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE:SMR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in NuScale, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/nuscale-class-action-l ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Plug Power Inc. (NASDAQ:PLUG) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Plug Power, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/plug-power-class-action-law ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Mister Car Wash, Inc.’s (NASDAQ: MCW) board of directors and its controlling stockholder, LGP, for potential breaches of their fiduciary duties to shareholders in connection with a potential take-private sale of Mister Car Wash that would cash out every public stockholder for $7 per share. If you are a current shareholder of Mister Car Wash, you are encouraged to obtain addition ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Wealthfront Corporation (NASDAQ: WLTH) for potential violations of the federal securities laws. If you invested in Wealthfront, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/wealthfront-corporation-class-action. Why is Wealthfront Being Investigated for Violations of the Federal Securities Laws? Wealthfront is an online financial ...

Core Viewpoint - PennyMac Financial Services, Inc. is under investigation for potential violations of federal securities laws related to its mortgage recapture efforts as interest rates declined [1][2][3]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is investigating whether PennyMac misrepresented its ability to recapture customers refinancing their mortgages during a period of declining interest rates [3]. - The investigation follows PennyMac's claims of improved recapture rates, which may not align with actual performance [2][3]. Group 2: Financial Performance and Stock Impact - On January 29, 2026, PennyMac reported disappointing financial results for Q4 2025, revealing that increased origination capacity did not translate into expected refinancing opportunities due to heightened competition [4]. - Following the earnings call, PennyMac's stock price dropped over 37%, from $140.70 per share to as low as $93.50 per share [4].

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...

Core Insights - Recursion has reached a pivotal moment, transitioning from demonstrating AI's role in drug discovery to showcasing an AI-native operating system that can generate clinical proof and sustainable value [3] - The company enters 2026 with five clinical programs advancing and over $500 million in milestone payments earned to date, reflecting a robust pipeline and disciplined execution strategy [3][6] Business Highlights - Recursion's pipeline is diversified, powered by its AI-native Recursion OS, with both wholly-owned and partnered programs [4] - The company achieved its first clinical validation of the Recursion OS in Familial Adenomatous Polyposis (FAP), with 75% of evaluable patients showing reductions in total polyp burden [6][9] - Recursion has received $134 million in milestone payments from its collaboration with Sanofi, with five discovery program packages accepted to date [6][14] Financial Performance - Total revenue for Q4 2025 was $35.5 million, a significant increase from $4.5 million in Q4 2024, driven by milestone payments and collaboration agreements [15] - Research and development expenses for Q4 2025 were $95.9 million, slightly lower than $98.3 million in Q4 2024, while total R&D expenses for the year were $475.3 million compared to $314.4 million in 2024 [15][22] - The net loss for Q4 2025 was $108.1 million, an improvement from a net loss of $178.9 million in Q4 2024, with a total net loss of $644.8 million for the year [15][22] Pipeline and Milestones - Recursion's pipeline includes several promising candidates, such as REC-4881 for FAP, REC-617 for advanced solid tumors, and REC-7735 for PI3Kα H1047R mutation [7][9] - Upcoming milestones include FDA engagement for REC-4881 and additional Phase 1/2 clinical data expected in 2026 [9][12] - The company anticipates further advancements in its partnered discovery programs, with potential for additional near-term milestones as programs progress [8][14] Cash Position - As of December 31, 2025, Recursion had cash and cash equivalents of $754 million, providing a runway into early 2028 without additional financing [6][15] - The company achieved a cash operating expense of approximately $399.2 million for 2025, reflecting improved operational efficiency [12][22]

Core Insights - Loblaw Companies Limited reported solid fourth quarter results for 2025, with a revenue increase of 11.3% to $16,382 million, driven by strong customer traffic and e-commerce growth [3][8][23] - The company continues to focus on strategic growth initiatives, including expanding its store network and enhancing its digital engagement platforms [19][21][22] Financial Performance - Revenue for the fourth quarter increased by $1,657 million, or 11.3%, with a comparable 12-week revenue growth of 3.5% [8][23] - Retail operating income rose by 43.0% to $1,134 million, while adjusted EBITDA increased by 11.3% to $1,775 million [8][23] - Net earnings available to common shareholders were $656 million, reflecting a 42.0% increase, with diluted net earnings per share rising by 44.7% to $0.55 [8][23] Sales Growth - Food Retail same-store sales increased by 1.5%, while Drug Retail same-store sales grew by 3.9% [8][23] - E-commerce sales saw a significant increase of 19.6%, highlighting the importance of omnichannel convenience for customers [3][8] Strategic Initiatives - The company opened 77 new stores in 2025 and ramped up its automated distribution centers to enhance operational efficiency [4][21][22] - Loblaw is focusing on its loyalty program, PC Optimum, to drive customer engagement and retention [19][21] Market Position - Loblaw's strong performance in the fourth quarter contributed to market share gains across its banners, supported by a focus on value, quality, and service [3][4] - The company is well-positioned to meet the evolving needs of Canadians, with a commitment to retail excellence and strategic investments for future growth [19][20]